Regulatory T cells and viral liver disease

Journal of Viral Hepatitis

Volumn 16, Issue 4, 2009, Pages 223-229

  Alatrakchi, Nadia ^a   Koziel, Margaret ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

CD4+CD25+Treg; CD8 Treg; HBV; HCV; Liver disease; TGF

Indexed keywords

CELL POPULATION; COMPREHENSION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; VIRUS HEPATITIS;

HEPATITIS B; HEPATITIS C; HEPATITIS, VIRAL, HUMAN; HUMANS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 61449152973     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2009.01081.x     Document Type: Review

References (78)

1. Sakaguchi S. Naturally arising Foxp3-expressing CD25 + CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005 6 (4 345 352.
2. Belkaid Y. Regulatory T cells and infection: a dangerous necessity. Nat Rev Immunol 2007 7 (11 875 888.
3. Belkaid Y, Rouse BT. Natural regulatory T cells in infectious disease. Nat Immunol 2005 6 (4 353 360.
4. Billerbeck E, Bottler T, Thimme R. Regulatory T cells in viral hepatitis. World J Gastroenterol 2007 13 (36 4858 4864.
5. Mills KH. Regulatory T cells: friend or foe in immunity to infection? Nat Rev Immunol 2004 4 (11 841 855.
6. Gershon RK, Kondo K. Infectious immunological tolerance. Immunology 1971 21 (6 903 914.
7. Gershon RK. A disquisition on suppressor T cells. Transplant Rev. 1975 26 : 170 185.
8. Gershon RK, Kondo K. Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology 1970 18 (5 723 737.
9. Powrie F, Mason D. OX-22high CD4+ T cells induce wasting disease with multiple organ pathology: prevention by the OX-22low subset. J Exp Med 1990 172 (6 1701 1708.
10. Sakaguchi S, Fukuma K, Kuribayashi K, Masuda T. Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J Exp Med 1985 161 (1 72 87.
11. Fowell D, Mason D. Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4+ T cell subset that inhibits this autoimmune potential. J Exp Med 1993 177 (3 627 636.
12. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995 155 (3 1151 1164.
13. Baecher-Allan C, Viglietta V, Hafler DA. Human CD4 + CD25+ regulatory T cells. Semin Immunol 2004 16 (2 89 98.
14. Chen W, Jin W, Hardegen N et al. Conversion of peripheral CD4 + CD25- naive T cells to CD4 + CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003 198 (12 1875 1886.
15. Zheng SG, Gray JD, Ohtsuka K, Yamagiwa S, Horwitz DA. Generation ex vivo of TGF-beta-producing regulatory T cells from CD4 + CD25- precursors. J Immunol 2002 169 (8 4183 4189.
16. Yamagiwa S, Gray JD, Hashimoto S, Horwitz DA. A role for TGF-beta in the generation and expansion of CD4 + CD25+ regulatory T cells from human peripheral blood. J Immunol 2001 166 (12 7282 7289.
17. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 2005 6 (12 1219 1227.
18. Apostolou I, von Boehmer H. In vivo instruction of suppressor commitment in naive T cells. J Exp Med 2004 199 (10 1401 1408.
19. Exley MA, Koziel MJ. To be or not to be NKT: natural killer T cells in the liver. Hepatology 2004 40 (5 1033 1040.
20. Nowak M, Stein-Streilein J. Invariant NKT cells and tolerance. Int Rev Immunol 2007 2 : 95 119.
21. Shevach EM. CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2002 2 (6 389 400.
22. Kingsley CI, Karim M, Bushell AR, Wood KJ. CD25 + CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol 2002 168 (3 1080 1086.
23. Shevach EM. From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 2006 25 (2 195 201.
24. Weiner HL. Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev 2001 182 : 207 214.
25. Billerbeck E, Blum HE, Thimme R. Parallel expansion of human virus-specific FoxP3- effector memory and de novo-generated FoxP3+ regulatory CD8+ T cells upon antigen recognition in vitro. J Immunol 2007 179 (2 1039 1048.
26. Endharti AT, Rifa IMs, Shi Z et al. Cutting edge: CD8 + CD122+ regulatory T cells produce IL-10 to suppress IFN-gamma production and proliferation of CD8+ T cells. J Immunol 2005 175 (11 7093 7097.
27. Rifa'i M, Kawamoto Y, Nakashima I, Suzuki H. Essential roles of CD8 + CD122+ regulatory T cells in the maintenance of T cell homeostasis. J Exp Med 2004 200 (9 1123 1134.
28. Sun D, Qin Y, Chluba J, Epplen JT, Wekerle H. Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions. Nature 1988 332 (6167 843 845.
29. Filaci G, Bacilieri S, Fravega M et al. Impairment of CD8+ T suppressor cell function in patients with active systemic lupus erythematosus. J Immunol 2001 166 (10 6452 6457.
30. Filaci G, Fravega M, Negrini S et al. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8 + CD28- T cells and inhibit both T-cell proliferation and CTL function. Hum Immunol 2004 65 (2 142 156.
31. Filaci G, Rizzi M, Setti M et al. Non-antigen-specific CD8(+) T suppressor lymphocytes in diseases characterized by chronic immune responses and inflammation. Ann N Y Acad Sci 2005 1050 : 115 123.
32. Takahashi T, Tagami T, Yamazaki S et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000 192 (2 303 310.
33. McHugh RS, Whitters MJ, Piccirillo CA et al. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002 16 (2 311 323.
34. Lehmann J, Huehn J, de la Rosa M et al. Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25- regulatory T cells. Proc Natl Acad Sci U S A 2002 99 (20 13031 13036.
35. Suffia I, Reckling SK, Salay G, Belkaid Y. A role for CD103 in the retention of CD4 + CD25+ Treg and control of Leishmania major infection. J Immunol 2005 174 (9 5444 5455.
36. Jaensson E, Uronen-Hansson H, Pabst O et al. Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans. J Exp Med 2008 205 (9 2139 2149.
37. Huang CT, Workman CJ, Flies D et al. Role of LAG-3 in regulatory T cells. Immunity 2004 21 (4 503 513.
38. Kinter AL, Hennessey M, Bell A et al. CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J Exp Med 2004 200 (3 331 343.
39. Wang R, Wan Q, Kozhaya L, Fujii H, Unutmaz D. Identification of a regulatory T cell specific cell surface molecule that mediates suppressive signals and induces Foxp3 expression. PLoS ONE 2008 3 (7 e2705.
40. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4 + CD25+ regulatory T cells. Nat Immunol 2003 4 (4 330 336.
41. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003 299 (5609 1057 1061.
42. Ebert LM, Tan BS, Browning J et al. The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells. Cancer Res 2008 68 (8 3001 3009.
43. Hartigan-O'Connor DJ, Poon C, Sinclair E, McCune JM. Human CD4+ regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells. J Immunol Methods 2007 2 : 41 52.
44. Liu W, Putnam AL, Xu-Yu Z et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006 203 (7 1701 1711.
45. Li S, Gowans EJ, Chougnet C, Plebanski M, Dittmer U. Natural regulatory T cells and persistent viral infection. J Virol 2008 82 (1 21 30.
46. Guidotti LG, Chisari FV. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001 19 : 65 91.
47. Maloy KJ, Powrie F. Regulatory T cells in the control of immune pathology. Nat Immunol 2001 2 (9 816 822.
48. Suvas S, Kumaraguru U, Pack CD, Lee S, Rouse BT. CD4 + CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses. J Exp Med 2003 198 (6 889 901.
49. Suvas S, Azkur AK, Kim BS, Kumaraguru U, Rouse BT. CD4 + CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions. J Immunol 2004 172 (7 4123 4132.
50. Benito JM, Lopez M, Soriano V. The role of CD8+ T-cell response in HIV infection. AIDS Rev. 2004 6 (2 79 88.
51. Goulder PJ, Watkins DI. HIV and SIV CTL escape: implications for vaccine design. Nat Rev Immunol 2004 4 (8 630 640.
52. Estes JD, Li Q, Reynolds MR et al. Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection. J Infect Dis 2006 193 (5 703 712.
53. Crispe IN. Hepatic T cells and liver tolerance. Nat Rev Immunol 2003 3 (1 51 62.
54. R cells accompanies the appearance of activated CD8 T cells in the liver. Hepatology 2008 48 (6 1954 1963.
55. Perrella A, Vitiello L, Atripaldi L et al. Impaired function of CD4 + /CD25+ T regulatory lymphocytes characterizes the self-limited hepatitis A virus infection. J Gastroenterol Hepatol 2008 23 (7 Pt 2 e105 e110.
56. Smyk-Pearson S, Golden-Mason L, Klarquist J et al. Functional suppression by FoxP3 + CD4 + CD25(high) regulatory T cells during acute hepatitis C virus infection. J Infect Dis 2008 197 (1 46 57.
57. Manigold T, Racanelli V. T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies. Lancet Infect Dis. 2007 7 (12 804 813.
58. Yang G, Liu A, Xie Q et al. Association of CD4 + CD25 + Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis B. Int Immunol 2007 19 (2 133 140.
59. Franzese O, Kennedy PT, Gehring AJ et al. Modulation of the CD8 + -T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection. J Virol 2005 79 (6 3322 3328.
60. Stoop JN, van der Molen RG, Baan CC et al. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 2005 41 (4 771 778.
61. Xu D, Fu J, Jin L et al. Circulating and liver resident CD4 + CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol 2006 177 (1 739 747.
62. Boettler T, Spangenberg HC, Neumann-Haefelin C et al. T cells with a CD4 + CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J Virol 2005 79 (12 7860 7867.
63. Rushbrook SM, Ward SM, Unitt E et al. Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection. J Virol 2005 79 (12 7852 7859.
64. Ward SM, Fox BC, Brown PJ et al. Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection. J Hepatol 2007 47 (3 316 324.
65. Ebinuma H, Nakamoto N, Li Y et al. Identification and in vitro expansion of functional antigen-specific CD25+ FoxP3+ regulatory T cells in hepatitis C virus infection. J Virol 2008 82 (10 5043 5053.
66. MacDonald AJ, Duffy M, Brady MT et al. CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons. J Infect Dis 2002 185 (6 720 727.
67. Bolacchi F, Sinistro A, Ciaprini C et al. Increased hepatitis C virus (HCV)-specific CD4 + CD25+ regulatory T lymphocytes and reduced HCV-specific CD4+ T cell response in HCV-infected patients with normal versus abnormal alanine aminotransferase levels. Clin Exp Immunol 2006 144 (2 188 196.
68. Accapezzato D, Francavilla V, Paroli M et al. Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection. J Clin Invest 2004 113 (7 963 972.
69. Abel M, Sene D, Pol S et al. Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection. Hepatology 2006 44 (6 1607 1616.
70. Alatrakchi N, Graham CS, van der Vliet HJ, Sherman KE, Exley MA, Koziel MJ. Hepatitis C virus (HCV)-specific CD8+ cells produce transforming growth factor beta that can suppress HCV-specific T-cell responses. J Virol 2007 81 (11 5882 5892.
71. Wahl SM. Transforming growth factor-beta: innately bipolar. Curr Opin Immunol 2007 19 (1 55 62.
72. Fantini MC, Becker C, Monteleone G, Pallone F, Galle PR, Neurath MF. Cutting edge: TGF-beta induces a regulatory phenotype in CD4 + CD25- T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 2004 172 (9 5149 5153.
73. Nakamura K, Kitani A, Strober W. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 2001 194 (5 629 644.
74. Cabrera R, Tu Z, Xu Y et al. An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 2004 40 (5 1062 1071.
75. Bettelli E, Carrier Y, Gao W et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006 441 (7090 235 238.
76. Schuppan D, Krebs A, Bauer M, Hahn EG. Hepatitis C and liver fibrosis. Cell Death Differ 2003 10 (Suppl. 1 S59 S67.
77. Hui AY, Dannenberg AJ, Sung JJ et al. Prostaglandin E2 inhibits transforming growth factor beta 1-mediated induction of collagen alpha 1(I) in hepatic stellate cells. J Hepatol 2004 41 (2 251 258.
78. Lechuga CG, Hernandez-Nazara ZH, Dominguez Rosales JA et al. TGF-beta1 modulates matrix metalloproteinase-13 expression in hepatic stellate cells by complex mechanisms involving p38MAPK, PI3-kinase, AKT, and p70S6k. Am J Physiol Gastrointest Liver Physiol 2004 287 (5 G974 G987.